You're using an outdated browser. Please upgrade to a modern browser for the best experience.
Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort by:
Most Viewed Latest Alphabetical (A-Z) Alphabetical (Z-A)
Filter:
All Topic Review Biography Peer Reviewed Entry Video Entry
Topic Review
Understanding COVID-19 Vaccines Today: Are T-cells Key Players?
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has heavily mutated since the beginning of the coronavirus-2019 (COVID-19) pandemic. In this regard, the so-called variants of concern (VOCs) feature mutations that confer increased transmissibility and evasion of antibody responses. The VOCs have caused significant spikes in COVID-19 cases, raising significant concerns about whether COVID-19 vaccines will protect against current and future variants. In this research, whereas the protection COVID-19 vaccines offer against the acquisition of infection appears compromised, the protection against severe COVID-19 is maintained. From an immunologic standpoint, this is likely underpinned by the maintenance of T-cell responses against VOCs. Therefore, the role of T-cells is essential to understanding the broader adaptive immune response to COVID-19, which has the potential to shape public policies on vaccine protocols and inform future vaccine design.
  • 828
  • 21 Jun 2022
Topic Review
Importance of Magnesium Status in COVID-19
Magnesium is an essential nutrient, also called an essential mineral or element. Magnesium is vastly important in all life, with vital roles for the healthy functioning of the human immune, metabolic, neurological, psychological, and heart and circulatory systems. Magnesium (Mg) status may have relevance for the outcome of COVID-19 and that Mg could be protective during the COVID disease course: (1) low magnesium status is associated with the severity of COVID-19 outcomes, including mortality, and with several disease-related neurological symptoms, including loss of memory, taste, and/or smell; (2) inhaled magnesium as a therapy may improve oxygen status; and (3) magnesium therapy, alone or in combination with zinc, may increase the effectiveness of anti-COVID-19 medications.
  • 828
  • 23 May 2023
Topic Review
Acute Infective Endocarditis
Infective endocarditis (IE) is a potentially fatal disease with a mortality rate of over 20%, largely unmodified over recent decades. Mechanisms of IE pathogenesis are still incompletely understood but involve bacteria, host immune responses and the coagulation system.
  • 827
  • 30 Nov 2021
Topic Review
Antibody-Mediated Alphavirus Immunity
Alphaviruses are mosquito-borne pathogens distributed worldwide in tropical and temperate areas causing a wide range of symptoms ranging from inflammatory arthritis-like manifestations to the induction of encephalitis in humans. Historically, large outbreaks in susceptible populations have been recorded followed by the development of protective long-lasting antibody responses suggesting a potential advantageous role for a vaccine.
  • 825
  • 04 Aug 2021
Topic Review
Detection of Sepsis in Platelets
The incidence of sepsis varies depending on the hospital studied, being higher in those dealing with more clinically severe patients, such as cancer hospitals.
  • 823
  • 09 Dec 2021
Topic Review
COVID-19 Associated Pulmonary Thrombosis
Pulmonary thrombosis in situ is a pathological condition nonrelated to embolism from deep vein thrombosis (DVT) in the lower extremities. 
  • 823
  • 04 Apr 2023
Topic Review
Hepatitis B Virus Core Protein in Hepatocarcinogenesis
Chronic hepatitis B virus (HBV) infection is one of the most common factors associated with hepatocellular carcinoma (HCC), which is the sixth most prevalent cancer among all cancers worldwide. The mechanisms underlying HBV-induced malignant transformation remain unclear, but some studies have suggested that the hepatitis B virus core (HBc) protein has a potential function in the pathogenesis of hepatocellular carcinoma in addition to the HBV X protein. This review focuses its discussion on the involvement of HBc in the development of hepatocellular carcinoma. 
  • 823
  • 14 Jan 2022
Topic Review
Clinical Manifestations of Human Exposure to Fungi
Biological particles, along with inorganic gaseous and particulate pollutants, constitute an ever-present component of the atmosphere and surfaces. Among these particles are fungal species colonizing almost all ecosystems, including the human body. Although inoffensive to most people, fungi can be responsible for several health problems, such as allergic fungal diseases and fungal infections. Worldwide fungal disease incidence is increasing, with new emerging fungal diseases appearing yearly. Reasons for this increase are the expansion of life expectancy, the number of immunocompromised patients (immunosuppressive treatments for transplantation, autoimmune diseases, and immunodeficiency diseases), the number of uncontrolled underlying conditions (e.g., diabetes mellitus), and the misusage of medication (e.g., corticosteroids and broad-spectrum antibiotics). 
  • 822
  • 05 May 2023
Topic Review
Acute Infectious Gastroenteritis
Acute infectious gastroenteritis (AGE) is defined as a diarrhoeal disease of rapid onset presenting with the incidence of three or more soft or liquid stools, or three bouts of vomiting per 24 h, with addition of abdominal pain, or fever.
  • 821
  • 10 Feb 2022
Topic Review
Novel Heterocyclic Derivatives against SARS-CoV-2
The heterocyclic ring derivatives were evaluated for their therapeutic potentials against SARS-CoV-2 Mpro, Spro, and RdRp. All the compounds reported showed excellent binding affinities with the various target proteins. Among the derivatives, compound C13 exhibits the highest binding affinity for the drug targets Spro (−10.6 kcal/mol) and RdRp (−9.5 kcal/mol), respectively. At a binding affinity of −8.8kcal/mol, the compound C15 exhibits the highest binding affinity for Mpro. The compounds interacted with the LEU A:271, LEU A:287, ASP A:289, and LEU A:272 of Mpro and the HIS A:540, PRO A:415, PHE A:486, and LEU A:370 of the Spro receptor binding motif and some active site amino acids of RdRp. The compounds also possess a favourable ADMET profile and showed no tendency towards hERG inhibition, hepatotoxicity, carcinogenicity, mutagenicity, or drug-liver injury. 
  • 820
  • 17 Dec 2021
Topic Review
Chronic Rhinosinusitis, S. aureus Biofilm and Secreted Products
Chronic rhinosinusitis (CRS) is a persistent inflammation of the nasal cavity and paranasal sinuses associated with tissue remodelling, dysfunction of the sinuses’ natural defence mechanisms, and induction of different inflammatory clusters. The etiopathogenesis of CRS remains elusive, and both environmental factors, such as bacterial biofilms and the host’s general condition, are thought to play a role. Bacterial biofilms have significant clinical relevance due to their potential to cause resistance to antimicrobial therapy and host defenses. Despite substantial medical advances, some CRS patients suffer from recalcitrant disease that is unresponsive to medical and surgical treatments. Those patients often have nasal polyps with tissue eosinophilia, S. aureus-dominant mucosal biofilm, comorbid asthma, and a severely compromised quality of life.
  • 820
  • 21 Jun 2022
Topic Review
Naturally Acquired Antibodies against Malaria
Here, we discuss naturally acquired antibodies in malaria, and the potentially harmful or beneficial effects of them.Most studies have focused on the inhibitory effect of antibodies, but we review both the beneficial as well as the potentially harmful roles of naturally acquired antibodies, as well as autoantibodies formed in malaria. We discuss different studies that have sought to understand acquired antibody responses against P. falciparum antigens, and potential problems when different antibodies are combined such as in naturally acquired immunity.
  • 817
  • 04 Aug 2021
Topic Review
Different Biomedical Cell Products in COVID-19 Treatment
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a single-stranded RNA virus, infectious agent of coronavirus disease 2019 (COVID-19). COVID-19 is a real challenge for the protective immunity. Some people do not respond to vaccination by acquiring an appropriate immunological memory. The risk groups for this particular infection such as the elderly and people with compromised immunity (cancer patients, pregnant women, etc.) have the most serious problems in developing an adequate immune response. Therefore, dendritic cell (DC) vaccines that are loaded ex vivo with SARS-CoV-2 antigens in the optimal conditions are promising for immunization. Lymphocyte effector cells with chimeric antigen receptor (CAR-lymphocytes) are currently used mainly as anti-tumor treatment. However, CAR-lymphocytes may be successfully employed to treat viral diseases including COVID-19. Allogenic anti-SARS-CoV-2 CAR-NK-cells may be used as an emergency treatment.
  • 817
  • 18 May 2022
Topic Review
MicroRNA Let-7 in the Immunopathology of COVID-19
COVID-19 has presented itself as a challenging task to medical teams and researchers throughout the world, since the outbreak of SARS-CoV-2 started in the Chinese city of Wuhan. There are still new variants emerging, and the knowledge about the mechanisms used by the virus to infect cells and perpetuate itself are still not well understood. The scientific community is still trying to catch up with the velocity of new variants and, consequently, the new physiological pathways that appear along with it. It is known that the new coronavirus plays a role in changing many molecular pathways to take control of the infected cells. Many of these pathways are related to control genomic expression of certain genes by epigenetic ways, allowing the virus to modulate immune responses and cytokines production. The let-7 family of microRNAs, for instance, are known to promote increased viral fusion in the target cell through a mechanism involving the transmembrane serine protease 2 (TMPRSS2). It was also demonstrated they are able to increase the inflammatory activity through the NF-κB/IL-6/let-7/LIN-28 axis. 
  • 817
  • 30 Mar 2023
Topic Review
COVID-19 Vaccination and Alcohol Consumption: Justification of Risks
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, pharmaceutical companies and research institutions have been actively working to develop vaccines, and the mass roll-out of vaccinations against COVID-19 began in January 2021. At the same time, during lockdowns, the consumption of alcoholic beverages increased. During the peak of vaccination, consumption remained at high levels around the world, despite the gradual relaxation of quarantine restrictions. Two of the popular queries on search engines were whether it is safe to drink alcohol after vaccination and whether this will affect the effectiveness of vaccines. Many studies have been published suggesting that excessive drinking not only worsens the course of an acute respiratory distress syndrome caused by the SARS-CoV-2 virus but can also exacerbate post-COVID-19 syndrome. Despite all sorts of online speculation, there is no specific scientific data on alcohol-induced complications after vaccination in the literature. Most of the published vaccine clinical trials do not include groups of patients with a history of alcohol-use disorders.
  • 816
  • 02 Feb 2023
Topic Review
Pathogenesis and Treatment of the Omicron BA.2 lineage
The epidemic curve of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is silently rising again. Worldwide, the dominant SARS-CoV-2 variant of concern (VOC) is Omicron, and its virological characteristics, such as transmissibility, pathogenicity, and resistance to both vaccine- and infection-induced immunity as well as antiviral drugs, are an urgent public health concern. The Omicron variant has five major sub-lineages; as of February 2022, the BA.2 lineage has been detected in several European and Asian countries, becoming the predominant variant and the real antagonist of the ongoing surge. Hence, although global attention is currently focused on dramatic, historically significant events and the multi-country monkeypox outbreak, this new epidemic is unlikely to fade away in silence. Many aspects of this lineage are still unclear and controversial, but its apparent replication advantage and higher transmissibility, as well as its ability to escape neutralizing antibodies induced by vaccination and previous infection, are rising global concerns. 
  • 815
  • 11 Jul 2022
Topic Review
Type I Interferons in Mycobacterium tuberculosis Infection
Tuberculosis (TB) is a leading cause of mortality due to infectious disease and rates have increased during the emergence of COVID-19, but many of the factors determining disease severity and progression remain unclear. Type I Interferons (IFNs) have diverse effector functions that regulate innate and adaptive immunity during infection with microorganisms. 
  • 813
  • 01 Mar 2023
Topic Review
Mycoplasma bovis Infections
Mycoplasma bovis is a cause of bronchopneumonia, mastitis and arthritis but may also affect other main organs in cattle such us the eye, ear or brain. M. bovis infections are responsible for substantial economic health and welfare problems worldwide. M. bovis has spread worldwide, including to countries for a long time considered free of the pathogen.
  • 812
  • 15 Nov 2022
Topic Review
Incidence and Risk Factors of Bilateral Herpetic Keratitis
Herpetic keratitis is the result of a corneal infection with Herpes Simplex Virus (HSV) and it is recognized as a leading cause of corneal blindness worldwide. Bilateral HSV keratitis is a rare clinical manifestation and consists of simultaneously occurring infection in both eyes.
  • 811
  • 21 Jun 2022
Topic Review
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases
Interleukins (ILs) are signaling molecules that are crucial in regulating immune responses during infectious diseases. Pro-inflammatory ILs contribute to the activation and recruitment of immune cells, whereas anti-inflammatory ILs help to suppress excessive inflammation and promote tissue repair. 
  • 811
  • 23 Jan 2024
  • Page
  • of
  • 32
Academic Video Service